A detailed history of Private Advisor Group, LLC transactions in Novavax Inc stock. As of the latest transaction made, Private Advisor Group, LLC holds 22,511 shares of NVAX stock, worth $200,573. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,511
Previous 22,475 0.16%
Holding current value
$200,573
Previous $284,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$10.71 - $17.11 $385 - $615
36 Added 0.16%
22,511 $284,000
Q2 2024

Aug 05, 2024

BUY
$3.89 - $20.97 $44,143 - $237,967
11,348 Added 101.99%
22,475 $284,000
Q1 2024

Apr 30, 2024

SELL
$3.76 - $6.02 $5,000 - $8,006
-1,330 Reduced 10.68%
11,127 $53,000
Q4 2023

Feb 06, 2024

BUY
$4.8 - $7.67 $6,225 - $9,947
1,297 Added 11.62%
12,457 $59,000
Q3 2023

Nov 02, 2023

BUY
$6.81 - $9.74 $75,999 - $108,698
11,160 New
11,160 $80,000
Q4 2022

Jan 18, 2023

BUY
$8.86 - $25.04 $11,358 - $32,101
1,282 Added 7.91%
17,484 $0
Q3 2022

Oct 14, 2022

SELL
$18.2 - $76.12 $21,676 - $90,658
-1,191 Reduced 6.85%
16,202 $295,000
Q2 2022

Jul 13, 2022

BUY
$36.28 - $75.29 $77,675 - $161,195
2,141 Added 14.04%
17,393 $895,000
Q1 2022

May 12, 2022

BUY
$69.73 - $142.9 $342,165 - $701,210
4,907 Added 47.43%
15,252 $1.12 Million
Q4 2021

Feb 10, 2022

SELL
$134.56 - $217.97 $92,577 - $149,963
-688 Reduced 6.24%
10,345 $1.48 Million
Q3 2021

Oct 14, 2021

BUY
$177.8 - $270.58 $341,553 - $519,784
1,921 Added 21.08%
11,033 $2.29 Million
Q2 2021

Aug 12, 2021

BUY
$121.0 - $257.67 $48,763 - $103,841
403 Added 4.63%
9,112 $1.94 Million
Q1 2021

Apr 22, 2021

SELL
$112.98 - $319.93 $21,918 - $62,066
-194 Reduced 2.18%
8,709 $1.58 Million
Q4 2020

Apr 01, 2021

BUY
$78.74 - $139.5 $97,322 - $172,422
1,236 Added 16.12%
8,903 $993,000
Q3 2020

Nov 02, 2020

BUY
$79.44 - $178.51 $273,829 - $615,323
3,447 Added 81.68%
7,667 $831,000
Q2 2020

Aug 17, 2020

BUY
$13.86 - $83.61 $58,489 - $352,834
4,220 New
4,220 $352,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $697M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.